Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Department of Physiology, Anatomy & Genetics (DPAG) Postdoctoral Research Scientist Dr Sophia Malandraki-Miller took part in a pilot careers mentoring session at Oxford High School. This exciting new engagement programme is a collaboration between Medical Sciences Division researchers and Oxford Biomedical Research Centre and aims to increase awareness of the variety of careers in biomedicine.

Dr Sophia Malandraki-Miller sat at a table holding a prosthetic heart in front of a stage at Oxford High School

Dr Sophia Malandraki-Miller, Postdoctoral Research Scientist in the Riley Group (DPAG) took part in a valuable new careers mentoring opportunity piloted in collaboration between the Medical Sciences Division's Next Generation Leaders Programme and Oxford Biomedical Research Centre (BRC). This exciting new engagement programme links local schools with research and healthcare professionals within the University of Oxford and the Oxford University Hospital NHS Foundation Trust, and aims to increase awareness of the variety of careers in biomedicine.

The pilot session took place at Oxford High School with volunteers each giving around an hour of their time to speak to 15-year-old students looking at the next steps in their academic careers. Students gathered around different tables in groups of 10, with researchers moving between each group answering questions about their jobs and how they got to where they are. 

Read the full story on the DPAG website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.